An immunosuppressive TME may be associated with a higher frequency of plasmacytoid DCs (pDCs) derived from NSCLC tissues, which are characterized by elevated expression levels of CD33 and PD-L1. Here, CD274 is linked to non-small cell lung carcinoma.